Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase

Vaccine

Volumn 27, Issue 5, 2009, Pages 773-785

  Pavlova, Sophia P ^a   Veits, Jutta ^a   Keil, Günther M ^a   Mettenleiter, Thomas C ^a   Fuchs, Walter ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Hemagglutinin (HA); Highly pathogenic avian influenza virus (HPAIV); Infectious laryngotracheitis virus (ILTV); Neuraminidase (NA)

Indexed keywords

DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; ILTOVIRUS RECOMBINANT VACCINE; LIVE VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVIAN INFLUENZA; CHICKEN; CONTROLLED STUDY; DRUG DESIGN; GENE DELETION; ILTOVIRUS; INFLUENZA VIRUS A H5N1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; ILTOVIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; NEURAMINIDASE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 58249131528     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.033     Document Type: Article

References (58)

1. Guy J.S., and Bagust T.J. Laryngotracheitis. In: Saif Y.M. (Ed). Diseases of poultry. 11th ed. (2003), Iowa State Press, Ames 121-134
2. Swayne D.E., and Halvorson D.A. Influenza. In: Saif Y.M. (Ed). Diseases of poultry. 11th ed. (2003), Iowa State Press, Ames 135-160
3. Williams R.A., Bennett M., Bradbury J.M., Gaskell R.M., Jones R.C., and Jordan F.T. Demonstration of sites of latency of infectious laryngotracheitis virus using the polymerase chain reaction. J Gen Virol 73 9 (1992) 2415-2420
4. Andreasen Jr. J.R., Glisson J.R., and Villegas P. Differentiation of vaccine strains and Georgia field isolates of infectious laryngotracheitis virus by their restriction endonuclease fragment patterns. Avian Dis 34 3 (1990) 646-656
5. Guy J.S., Barnes H.J., and Smith L. Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Dis 35 2 (1991) 348-355
6. Kotiw M., Wilks C.R., and May J.T. The effect of serial in vivo passage on the expression of virulence and DNA stability of an infectious laryngotracheitis virus strain of low virulence. Vet Microbiol 45 1 (1995) 71-80
7. Fuchs W., Veits J., Helferich D., Granzow H., Teifke J.P., and Mettenleiter T.C. Molecular biology of avian infectious laryngotracheitis virus. Vet Res 38 2 (2007) 261-279
8. Lüschow D., Werner O., Mettenleiter T.C., and Fuchs W. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19 30 (2001) 4249-4259
9. Veits J., Lüschow D., Kindermann K., Werner O., Teifke J.P., Mettenleiter T.C., et al. Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol 84 12 (2003) 3343-3352
10. Capua I., and Alexander D.J. Avian influenza: recent developments. Avian Pathol 33 4 (2004) 393-404
11. Capua I., and Alexander D.J. Animal and human health implications of avian influenza infections. Biosci Rep 27 6 (2007) 359-372
12. van Oirschot J.T. Diva vaccines that reduce virus transmission. J Biotechnol 73 2-3 (1999) 195-205
13. Crawford J., Wilkinson B., Vosnesensky A., Smith G., Garcia M., Stone H., et al. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17 18 (1999) 2265-2274
14. Hunt L.A., Brown D.W., Robinson H.L., Naeve C.W., and Webster R.G. Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J Virol 62 8 (1988) 3014-3019
15. Robinson H.L., Hunt L.A., and Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11 9 (1993) 957-960
16. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 80 4 (2006) 1959-1964
17. Taylor J., Weinberg R., Kawaoka Y., Webster R.G., and Paoletti E. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6 6 (1988) 504-508
18. Swayne D.E., Suarez D.L., Schultz-Cherry S., Tumpey T.M., King D.J., Nakaya T., et al. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis 47 3 Suppl. (2003) 1047-1050
19. Veits J., Wiesner D., Fuchs W., Hoffmann B., Granzow H., Starick E., et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 103 21 (2006) 8197-8202
20. Qiao C.L., Yu K.Z., Jiang Y.P., Jia Y.Q., Tian G.B., Liu M., et al. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol 32 1 (2003) 25-32
21. Chen Z., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., et al. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17 7-8 (1999) 653-659
22. Johansson B.E. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine. Vaccine 17 15-16 (1999) 2073-2080
23. de Boer G.F., Back W., and Osterhaus A.D. An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species. Arch Virol 115 1-2 (1990) 47-61
24. Starick E., Werner O., Schirrmeier H., Köllner B., Riebe R., and Mundt E. Establishment of a competitive ELISA (cELISA) system for the detection of influenza A virus nucleoprotein antibodies and its application to field sera from different species. J Vet Med B: Infect Dis Vet Public Health 53 8 (2006) 370-375
25. Swayne D.E., Beck J.R., and Kinney N. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis 44 1 (2000) 132-137
26. Alexander D.J. Newcastle disease. In: Saif Y.M. (Ed). Diseases of poultry. 11th ed. (2003), Iowa State Press, Ames 64-87
27. Römer-Oberdörfer A., Veits J., Helferich D., and Mettenleiter T.C. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. Vaccine 26 19 (2008) 2307-2313
28. Veits J., Römer-Oberdörfer A., Helferich D., Durban M., Suezer Y., Sutter G., et al. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 26 13 (2008) 1688-1696
29. Ryan P., and Shankly F.L. A double-strand break in a herpesvirus genome stimulates targeted homologous recombination with exogenous, cloned viral sequences. J Virol Methods 57 1 (1996) 95-107
30. Le Hir H., Nott A., and Moore M.J. How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci 28 4 (2003) 215-220
31. Fuchs W., and Mettenleiter T.C. DNA sequence and transcriptional analysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis virus. J Gen Virol 77 9 (1996) 2221-2229
32. Kawaguchi T., Nomura K., Hirayama Y., and Kitagawa T. Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. Cancer Res 47 16 (1987) 4460-4464
33. Arnold B., Messerle M., Jatsch L., Küblbeck G., and Koszinowski U. Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen. Proc Natl Acad Sci USA 87 5 (1990) 1762-1766
34. Rapp M., Messerle M., Bühler B., Tannheimer M., Keil G.M., and Koszinowski U.H. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J Virol 66 7 (1992) 4399-4406
35. Mackett M., Smith G.L., and Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49 3 (1984) 857-864
36. Fuchs W., Klupp B.G., Granzow H., Osterrieder N., and Mettenleiter T.C. The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature virions. J Virol 76 1 (2002) 364-378
37. Fuchs W., Ziemann K., Teifke J.P., Werner O., and Mettenleiter T.C. The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor. J Gen Virol 81 3 (2000) 627-638
38. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
39. Helferich D., Veits J., Mettenleiter T.C., and Fuchs W. Identification of transcripts and protein products of the UL31, UL37, UL46, UL47, UL48, UL49 and US4 gene homologues of avian infectious laryngotracheitis virus. J Gen Virol 88 3 (2007) 719-731
40. Veits J., Köllner B., Teifke J.P., Granzow H., Mettenleiter T.C., and Fuchs W. Isolation and characterization of monoclonal antibodies against structural proteins of infectious laryngotracheitis virus. Avian Dis 47 2 (2003) 330-342
41. Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40 9 (2002) 3256-3260
42. Thureen D.R., and Keeler Jr. C.L. Psittacid herpesvirus 1 and infectious laryngotracheitis virus: comparative genome sequence analysis of two avian alphaherpesviruses. J Virol 80 16 (2006) 7863-7872
43. Palese P., and Shaw M.L. Orthomyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 5th ed. (2007), Lippincott Williams & Wilkins, Philadelphia 1647-1689
44. Kornfeld R., and Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54 (1985) 631-664
45. Kongsuwan K., Johnson M.A., Prideaux C.T., and Sheppard M. Identification of an infectious laryngotracheitis virus gene encoding an immunogenic protein with a predicted M(r) of 32 kilodaltons. Virus Res 29 2 (1993) 125-140
46. Swayne D.E., Lee C.W., and Spackman E. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathol 35 2 (2006) 141-146
47. Messerle M., Crnkovic I., Hammerschmidt W., Ziegler H., and Koszinowski U.H. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 94 26 (1997) 14759-14763
48. Peeters B.P., de Leeuw O.S., Koch G., and Gielkens A.L. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol 73 6 (1999) 5001-5009
49. Römer-Oberdörfer A., Mundt E., Mebatsion T., Buchholz U.J., and Mettenleiter T.C. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J Gen Virol 80 11 (1999) 2987-2995
50. Tripathy D.N., and Reed W.M. Pox. In: Saif Y.M. (Ed). Diseases of poultry. 11th ed. (2003), Iowa State Press, Ames 253-269
51. Lamb R.A., and Parks G.D. Paramyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 5th ed. (2007), Lippincott Williams & Wilkins, Philadelphia 1449-1496
52. Mettenleiter T.C. Herpesvirus assembly and egress. J Virol 76 4 (2002) 1537-1547
53. Devlin J.M., Browning G.F., Hartley C.A., Kirkpatrick N.C., Mahmoudian A., Noormohammadi A.H., et al. Glycoprotein G is a virulence factor in infectious laryngotracheitis virus. J Gen Virol 87 10 (2006) 2839-2847
54. Fuchs W., Wiesner D., Veits J., Teifke J.P., and Mettenleiter T.C. In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs. J Virol 79 2 (2005) 705-716
55. Helferich D., Veits J., Teifke J.P., Mettenleiter T.C., and Fuchs W. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens. J Gen Virol 88 3 (2007) 732-742
56. Schnitzlein W.M., Winans R., Ellsworth S., and Tripathy D.N. Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus. Virology 209 2 (1995) 304-314
57. Sylte M.J., Hubby B., and Suarez D.L. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 5 19 (2007) 3763-3772
58. Swayne DE. Avian influenza vaccines and therapies for poultry. Comp Immunol Microbiol Infect Dis, in press, doi:10.1016/j.cimid.2008.01.006.